The U.S. Food and Drug Administration will now require COVID-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition ...
Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose. This price model comes down to ...
With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
In their NEJM commentary, the former FDA heads stated, “We are deeply concerned by sweeping new FDA assertions about vaccine safety and proposals that would undermine a regulatory model designed to ...
NEW YORK CITY -- Americans may need to get a single COVID-19 vaccination every year, federal health officials said Tuesday, making clear that the country will be living with the coronavirus for the ...
Novavax Inc. (NASDAQ:NVAX) shares surged after the company announced its plans to deliver a regulator-recommended vaccine against a strain of Covid-19 by September. What Happened: The Maryland-based ...
WASHINGTON — Drugstores are ready to deliver updated COVID-19 vaccines this fall and insurers plan to pay for them, even though the shots no longer come recommended by an important government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback